Table 3 –
Variable | OR | 95% CI | p value |
---|---|---|---|
Outcome | |||
EF recovery at 12 mo | 0.94 | 0.90–0.99 | 0.01 |
EF recovery at 24 mo | 0.93 | 0.88–0.98 | 0.01 |
Use of PDE5is at 12 mo | 1.02 | 0.97–1.06 | 0.5 |
Use of PDE5is at 24 mo | 0.90 | 0.83–0.97 | 0.008 |
Baseline characteristics | |||
CCI score (0 vs >=1) | 1.08 | 1.02–1.15 | 0.008 |
ORP | 0.87 | 0.82–0.91 | <0.0001 |
LRP | 0.81 | 0.77–0.85 | <0.0001 |
RARP | 1.33 | 1.27–1.40 | <0.0001 |
Coefficient | |||
Baseline IIEF-6 score | –0.35 | –0.54 to –0.16 | 0.0003 |
Age | 0.45 | 0.29–0.61 | <0.0001 |
CI = confidence interval; CCI = Charlson comorbidity index; EF = erectile function; IIEF = International Index of Erectile Function; IQR = interquartile range; LRP = laparoscopic radical prostatectomy; OR = odds ratio; ORP = open radical prostatectomy; PCa = prostate cancer; PDE5is = phosphodiesterase type 5 inhibitors; RARP = robot-assisted radical prostatectomy.